Revelation Biosciences In... (REVB)
NASDAQ: REVB
· Real-Time Price · USD
2.69
0.11 (4.26%)
At close: Aug 18, 2025, 3:59 PM
4.26% (1D)
| Bid | 2.53 |
| Market Cap | 4.57M |
| Revenue (ttm) | 26.96K |
| Net Income (ttm) | -14.41M |
| EPS (ttm) | 866.22 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.41 |
| Analyst | n/a |
| Ask | 2.88 |
| Volume | 90,677 |
| Avg. Volume (20D) | 458,190 |
| Open | 2.62 |
| Previous Close | 2.58 |
| Day's Range | 2.62 - 2.79 |
| 52-Week Range | 2.11 - 168.00 |
| Beta | -0.05 |
About REVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol REVB
Website n/a
2 months ago
-54.4%
Revelation Biosciences shares are trading lower af...
Unlock content with
Pro Subscription
6 months ago
-23.84%
Revelation Biosciences shares are trading lower after the company announced plans for a 1-for-16 reverse stock split.
1 month ago · businesswire.com
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME StudySAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing inflammation to op...
2 months ago · businesswire.com
Revelation Biosciences, Inc. Announces Closing of $4 Million Public OfferingSAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...
